Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients

View source ↗

Summary

A study sponsored by Boryung Pharmaceutical to evaluate ethanol-induced symptoms and safety in patients with breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Breast Cancer | Status: RECRUITING